X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TORRENT PHARMA ALKEM LABORATORIES/
TORRENT PHARMA
 
P/E (TTM) x - 29.0 - View Chart
P/BV x 7.5 5.5 136.5% View Chart
Dividend Yield % 0.6 1.0 58.3%  

Financials

 ALKEM LABORATORIES   TORRENT PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TORRENT PHARMA
Mar-17
ALKEM LABORATORIES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5891,768 89.9%   
Low Rs1,2321,186 103.9%   
Sales per share (Unadj.) Rs417.5346.1 120.6%  
Earnings per share (Unadj.) Rs56.355.2 102.0%  
Cash flow per share (Unadj.) Rs64.773.3 88.3%  
Dividends per share (Unadj.) Rs12.7014.00 90.7%  
Dividend yield (eoy) %0.90.9 95.0%  
Book value per share (Unadj.) Rs292.9257.1 114.0%  
Shares outstanding (eoy) m119.57169.22 70.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.3 79.2%   
Avg P/E ratio x25.126.8 93.6%  
P/CF ratio (eoy) x21.820.1 108.2%  
Price / Book Value ratio x4.85.7 83.8%  
Dividend payout %22.625.4 88.9%   
Avg Mkt Cap Rs m168,653249,887 67.5%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m9,1719,934 92.3%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m49,91558,569 85.2%  
Other income Rs m1,6452,233 73.7%   
Total revenues Rs m51,56160,802 84.8%   
Gross profit Rs m8,48213,773 61.6%  
Depreciation Rs m1,0063,069 32.8%   
Interest Rs m6712,056 32.6%   
Profit before tax Rs m8,45110,881 77.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6061,545 103.9%   
Profit after tax Rs m6,7319,336 72.1%  
Gross profit margin %17.023.5 72.3%  
Effective tax rate %19.014.2 133.8%   
Net profit margin %13.515.9 84.6%  
BALANCE SHEET DATA
Current assets Rs m27,06253,841 50.3%   
Current liabilities Rs m15,32431,612 48.5%   
Net working cap to sales %23.538.0 62.0%  
Current ratio x1.81.7 103.7%  
Inventory Days Days6797 68.4%  
Debtors Days Days4184 49.3%  
Net fixed assets Rs m12,61042,079 30.0%   
Share capital Rs m239846 28.3%   
"Free" reserves Rs m34,49042,655 80.9%   
Net worth Rs m35,02743,501 80.5%   
Long term debt Rs m1,21222,408 5.4%   
Total assets Rs m54,387101,250 53.7%  
Interest coverage x13.66.3 216.1%   
Debt to equity ratio x00.5 6.7%  
Sales to assets ratio x0.90.6 158.7%   
Return on assets %13.611.3 121.0%  
Return on equity %19.221.5 89.5%  
Return on capital %24.919.6 126.6%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56320,066 32.7%   
Fx outflow Rs m3,0125,304 56.8%   
Net fx Rs m3,55214,762 24.1%   
CASH FLOW
From Operations Rs m7,25910,127 71.7%  
From Investments Rs m1,864-7,869 -23.7%  
From Financial Activity Rs m-9,273-1,918 483.5%  
Net Cashflow Rs m-150212 -70.9%  

Share Holding

Indian Promoters % 66.9 71.5 93.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 7.0 471.5%  
FIIs % 0.0 12.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 8.8 -  
Shareholders   68,381 26,511 257.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  SANOFI INDIA  PANACEA BIOTECH  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 19, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS